Cipla

Stempeutics receives Japan process patent for its stem cell drug ‘Stempeucel’

Read more

Cipla gets US FDA approval for Lopinavir and ritonavir oral pellets

Read more

Cipla, Serum Institute agreement

Read more

Cipla launches generic drug Sofosbuvir in India

Read more

Cipla wins US$ 188.95 million of Global Fund ARV tender

Read more

Cipla’s arm Meditab sells stake in Jiangsu for $18.5 million

Read more

Meda Pharmaceuticals and Cipla sue Apotex to enforce Dymista patents

Read more

Cipla in distribution agreement with SII for paediatric vaccines in Europe

Read more